Trial intelligence / Profile preview

SELDDEC Trial

2017-003670-14Phase 4Active

Sponsor
University Hospital Limerick
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of neomycin and erythromycin in surgical site infection (SSI) (2 arms), sponsored by University Hospital Limerick. Primary endpoint: Incidence of surgical site infections. Started Sep 2017; status: active.

02

Drugs

neomycinerythromycin
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on 2017-003670-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-003670-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call